Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


Translational CNS Summit

21 May 2013 - 23 May 2013 - Boston, MA, USA



Bookmark and Share


Increase the translational potential of your CNS therapies

Bridge the Translational Gap

CNS diseases are a huge unmet medical need in our society. Why? Because CNS drug discovery is notoriously difficult. But for the companies that get it right and produce new successful therapeutics, the rewards, both commercially and socially will be huge. So what can be done to ensure more CNS drugs make it to market?

The problems drug developers face tend to be very similar across the industry. Unreliable animal models. Validating new biomarkers. Detecting if a drug has reached the brain. However the solutions to tackle these problems are different across the board. There is a real hunger for a consolidation of ideas to decide what is best practice.


Translational CNS is first and foremost a summit, a meeting of leading minds in the CNS field. Where the key issues can be discussed, where progress can be made, where people can decide how to mitigate risk of failure.

The agenda has been designed by experts from Eli Lilly, Takeda, Eisai and more. It will cover how to avoid the pitfalls that cause CNS drugs to fail and enable you to increase the clinical success rate of your CNS drugs

Key topics covered include:

Designing animal models with improved predictive validity

Optimizing the use of imaging within your clinical development

Identifying and validating new biomarkers of CNS disease

Bridging the gap between preclinical and clinical developmente the translational potential of your CNS therapies

Bridge the Translational Gap

CNS diseases are a huge unmet medical need in our society. Why? Because CNS drug discovery is notoriously difficult. But for the companies that get it right and produce new successful therapeutics, the rewards, both commercially and socially will be huge. So what can be done to ensure more CNS drugs make it to market?

The problems drug developers face tend to be very similar across the industry. Unreliable animal models. Validating new biomarkers. Detecting if a drug has reached the brain. However the solutions to tackle these problems are different across the board. There is a real hunger for a consolidation of ideas to decide what is best practice.

Translational CNS is first and foremost a summit, a meeting of leading minds in the CNS field. Where the key issues can be discussed, where progress can be made, where people can decide how to mitigate risk of failure.

The agenda has been designed by experts from Eli Lilly, Takeda, Eisai and more. It will cover how to avoid the pitfalls that cause CNS drugs to fail and enable you to increase the clinical success rate of your CNS drugs

Key topics covered include:

Designing animal models with improved predictive validity

Optimizing the use of imaging within your clinical development

Identifying and validating new biomarkers of CNS disease

Bridging the gap between preclinical and clinical development



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Atmosphere Acidity Minimised to Preindustrial Levels
Sheet ice study shows acidic pollution of the atmosphere has now almost returned to preindustrial levels.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
“Sixth Sense” More Than a Feeling
NIH study of rare genetic disorder reveals importance of touch and body awareness.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!